person

Brieuc S.

Country
Belgium
Department
Medical Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
107
Sites with multiple studies

Has run more than one trial at 107 of 278 partner sites.

Specializations

Oncology – Solid Tumors

Focused on advanced breast cancer, lung cancer, and gastro‑intestinal malignancies with an emphasis on molecularly defined subgroups.

  • Hormone‑receptor‑positive, HER2‑negative breast cancer
  • KRAS‑G12C‑mutated non‑small cell lung cancer
  • HER2‑expressing gastric and gastroesophageal junction adenocarcinoma
  • Colorectal cancer with BRAF V600E mutation
  • Advanced ovarian and fallopian tube carcinoma

Research supports targeted and immuno‑oncologic strategies for patients with limited treatment options.

Hematology – Malignant Blood Disorders

Investigations span acute and chronic leukemias, lymphomas, and plasma‑cell neoplasms.

  • Acute myeloid leukemia (AML) with IDH1 mutation
  • Acute lymphoblastic leukemia in young adults
  • Diffuse large B‑cell lymphoma (DLBCL)
  • Multiple myeloma, including relapsed/refractory disease
  • Chronic lymphocytic leukemia (CLL)

Efforts aim to improve survival through novel agents and combination regimens.

Autoimmune & Inflammatory Disorders

Extensive work on systemic and organ‑specific autoimmune conditions.

  • Systemic lupus erythematosus (SLE)
  • Psoriatic arthritis
  • Moderate‑to‑severe plaque psoriasis
  • Rheumatoid arthritis
  • Inflammatory bowel disease (Crohn’s disease and ulcerative colitis)

Therapeutic focus includes biologics and targeted immunomodulators.

Respiratory & Pulmonary Diseases

Key interests cover chronic obstructive pulmonary disease, interstitial lung disease, and acute respiratory syndromes.

  • Chronic obstructive pulmonary disease (COPD)
  • Idiopathic pulmonary fibrosis (IPF)
  • Systemic sclerosis‑associated interstitial lung disease
  • Severe asthma
  • Acute respiratory distress syndrome (ARDS)

Research targets disease progression and lung function preservation.

Metabolic, Renal & Cardiovascular Health

Investigations address metabolic dysfunction, kidney disease, and cardiovascular risk.

  • Non‑alcoholic steatohepatitis (NASH)
  • Chronic kidney disease (CKD) with hypertension
  • Obesity and overweight associated with ASCVD
  • Type 2 diabetes prevention
  • Alport syndrome and focal segmental glomerulosclerosis

Therapeutic development seeks to modify disease pathways and improve organ outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.